ABLE celebrated its 20th Anniversary Celebration on 24th February at Novotel Hyderabad Convention Centre in Hyderabad. The occasion was graced by the presence of two co-founders of ABLE - Dr. Varaprasad Reddy, Co-Founder of ABLE and Founder of Shantha Biotechnics, and Dr. Villoo Morawala-Patell, Co-Founder of ABLE and Founder & CMD of Avesthagen.

The event was a joyous celebration of ABLE's remarkable journey and accomplishments in the biotechnology industry over the past two decades. Attendees enjoyed engaging discussions and insights from notable speakers, including government officials, industry leaders, and entrepreneurs. The presence of the two co-founders served as a testament to ABLE's tremendous impact in shaping and advancing the biotechnology landscape in India. Overall, the 20th Anniversary Celebration was a resounding success and a true reflection of ABLE's ongoing commitment to promoting the growth and development of the biotechnology industry in India.

**************************************************

 

Panel discussion on Advancing Biotechnology: R&D and Building Infrastructure Imperatives

The session was moderated by Angel Investor and MD of Garphi Biosciences, Mr. Venkat Kamalakar Bundla.

The experts in the biotech industry gathered to discuss the imperative need for advancing biotechnology through research and infrastructure development.

The panelists, consisting of esteemed individuals in the biotech field, including Mr. Prasanta Biswal, Director of TCG International Biotech Park, Dr. Bala Reddy, Whole-Time Director of Hetero Biopharma, Mr. Debashish Banerjee, Head of Innovation and Strategy at Novartis, and Dr. Sanjay Chaturvedi, CEO of IOL Chemicals and Pharmaceuticals Limited, sharing their insights on how research and infrastructure development are key to advancing biotechnology in India. The discussion touched upon various topics, including the importance of funding for R&D, infrastructure development for better innovation, and how to attract more investors to the biotech industry.

**************************************************

 

Panel discussion on Navigating the Intersection of Regulation and Emerging Technologies: AI, MI, and Beyond

The session was moderated by Dr. Deepanwita Chattopadhyay, Chairman & CEO of IKP Knowledge Park, and featured a panel of experts in the field. The panelists included Dr. A. Ramkishan, DDC (India) of CDSCO Zonal Office in Hyderabad, Dr. Anu Acharya, CEO of MapmyGenome, Mr. Ram Chereddy, Co-Founder & Director of Loka Biosciences, and Mr. Matruprasad Priyadarshi, Senior Director Region & Program Operations, South Asia of USP.

During the discussion, the panelists explored the challenges of regulating new technologies such as artificial intelligence and machine learning in the biotech industry. They also discussed the impact of emerging technologies on regulatory frameworks and the need for collaboration between industry and regulators to ensure safe and effective innovation.

ABLE celebrated its 20th Anniversary Celebration on 24th February at Novotel Hyderabad Convention Centre in Hyderabad.